Funding for this research was provided by:
Ohio Development Services Agency (TECH 09-028, TECH 13-060)
Article History
Received: 20 July 2018
Accepted: 10 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: The study (NCT02283125) was approved by the institutional review board, and all subjects signed an informed consent.
: The study (NCT02283125) was approved by the institutional review board, and all subjects signed an informed consent.
: The first and senior authors declare that they have no competing interests. PM is an employee of Philips and Director of Clinical Science. He was the Philips co-PI of the clinical trials performed.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.